Related references
Note: Only part of the references are listed.Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Joseph Meserve et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Long-Term Outcomes of Immunosuppression-Naive Steroid Responders Following Hospitalization for Ulcerative Colitis
Amar Vedamurthy et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Infliximab, Azathioprine, or Infliximab + Azathioprine for Treatment of Moderate to Severe Ulcerative Colitis: The UC Success Trial
Remo Panccione et al.
GASTROENTEROLOGY (2018)
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frederic Colombel et al.
GUT (2017)
Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities
Ashwin N. Ananthakrishnan et al.
INFLAMMATORY BOWEL DISEASES (2017)
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
Magali Lemaitre et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents
Jordan Axelrad et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis
Edward Shelton et al.
GASTROENTEROLOGY (2016)
First Do No Harm: Is It Safe to Use Immunosuppressants in Inflammatory Bowel Disease Patients With Prior Cancer?
Geoffrey C. Nguyen
GASTROENTEROLOGY (2016)
Complications of biologics in inflammatory bowel disease
Paula Sousa et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Vito Annese et al.
JOURNAL OF CROHNS & COLITIS (2015)
Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer
Laurent Beaugerie et al.
GUT (2014)
Natural History of Crohn's Disease Following Total Colectomy and End Ileostomy
Joanna Lopez et al.
INFLAMMATORY BOWEL DISEASES (2014)
Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
Amit Desai et al.
INFLAMMATORY BOWEL DISEASES (2013)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy A Meta-analysis
Maria A. Lopez-Olivo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2011)
Influence of Anti-Tumor Necrosis Factor Therapy on Cancer Incidence in Patients With Rheumatoid Arthritis Who Have Had a Prior Malignancy: Results From the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS CARE & RESEARCH (2010)
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
Anja Strangfeld et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
